SCHEMBL3788922

SCHEMBL3788922

COC1(CO)O[C@H](CO)[C@@H](O)[C@@H]1O

nearest known ligand 0.48

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 1/20 0.48
CCNB1 P14635 1/20 0.48
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
PYGB P11216 6/20 0.39
PYGL P06737 3/20 0.33
PYGM P11217 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
MGAM O43451 2/20 0.31
SI P14410 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3788926 1.00 CDK1 (0.48) CDK1CCNB1CA2CA9PYGB
SCHEMBL10910299 1.00 CDK1 (0.48) CDK1CCNB1CA2CA9PYGB
SCHEMBL13710964 1.00 CDK1 (0.48) CDK1CCNB1CA2CA9PYGB
SCHEMBL13699262 1.00 CDK1 (0.48) CDK1CCNB1CA2CA9PYGB
SCHEMBL13264607 1.00 CDK1 (0.48) CDK1CCNB1CA2CA9PYGB
SCHEMBL8817452 1.00 CDK1 (0.48) CDK1CCNB1CA2CA9PYGB
SCHEMBL10910296 1.00 CDK1 (0.48) CDK1CCNB1CA2CA9PYGB
SCHEMBL12588449 1.00 CDK1 (0.48) CDK1CCNB1CA2CA9PYGB
SCHEMBL15516528 0.88 CDK1 (0.37) CDK1CCNB1CA2CA9PYGB
SCHEMBL12733144 0.87 CDK1 (0.38) CDK1CCNB1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116925335-A Methyl fructoside polyether amine and preparation method and application thereof 浙江皇马科技股份有限公司 2023-10-24 CN claimed
EP-0507323-B1 Process for preparing fatty acid esters of saccharides LION CORP (JP) 1997-01-29 EP claimed
CN-116925335-A Methyl fructoside polyether amine and preparation method and application thereof 浙江皇马科技股份有限公司 2023-10-24 CN disclosed
EP-3004126-B1 PROCESS FOR PRODUCING A FRUCTOSIDE-CONTAINING PRODUCT FURANIX TECHNOLOGIES BV (NL) 2020-04-15 EP disclosed
US-10246477-B2 Isomerisation of C4-C6 aldoses with zeolites DANMARKS TEKNISKE UNIVERSITET (DK) 2019-04-02 US disclosed
US-10246477-B2 Isomerisation of C4-C6 aldoses with zeolites DANMARKS TEKNISKE UNIVERSITET (DK) 2019-04-02 US disclosed
US-9902750-B2 Process for producing a fructoside-containing product Synvina C.V. (NL) 2018-02-27 US disclosed
US-9469619-B2 Method of preparing furfural compounds SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-10-18 US disclosed
EP-2892907-B1 ISOMERISATION OF C4-C6 ALDOSES WITH ZEOLITES UNIV DANMARKS TEKNISKE (DK) 2016-06-01 EP disclosed
EP-2892907-B1 ISOMERISATION OF C4-C6 ALDOSES WITH ZEOLITES UNIV DANMARKS TEKNISKE (DK) 2016-06-01 EP disclosed
US-20160130292-A1 PROCESS FOR PRODUCING A FRUCTOSIDE-CONTAINING PRODUCT FURANIX TECHNOLOGIES B.V. (NL) 2016-05-12 US disclosed
EP-1627882-B1 Process for the preparation of alkypolyglycosides GOLDSCHMIDT GMBH (DE) 2006-11-22 EP disclosed
EP-1627882-A1 Process for the preparation of alkypolyglycosides Goldschmidt GmbH (DE) 2006-02-22 EP disclosed
US-20050261484-A1 Process for preparing alkylglycosides GOLDSCHMIDT GMBH (DE) 2005-11-24 US disclosed
CN-1405113-A Processing assistant for preparing cement DOW CORNING (US) 2003-03-26 CN disclosed
EP-0707590-A1 DIDEOXYFRUCTONUCLEOTIDES AND DEOXYFRUCTONUCLEOTIDES AS DNA POLYMERASE SUBSTRATES DU PONT (US) 1996-04-24 EP disclosed
WO-1995001986-A1 DIDEOXYFRUCTONUCLEOTIDES AND DEOXYFRUCTONUCLEOTIDES AS DNA POLYMERASE SUBSTRATES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1995-01-19 WO disclosed
WO-1994009019-A1 PROCESS FOR THE PREPARATION OF ALKYLGLYCOSIDES UNICHEMA CHEMIE B.V. (NL) 1994-04-28 WO disclosed
US-5276143-A Dideoxyfructonucleosides and deoxyfructonucleotides E. I. DU PONT DE NEMOURS AND COMPANY (US) 1994-01-04 US disclosed
EP-0252837-B1 PROCESS FOR THE PREPARATION OF DIANHYDRIDES OF FRUCTOFURANOSE AND THEIR USE AS NUTRITIVE ADDITIVES ERIDANIA BEGHIN-SAY (FR) 1992-11-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261484-A1 Process for preparing alkylglycosides UGGT1, OSTC, UGCG CDK1 2378/4885CCNB1 939/4885CA2 3896/4885
US-10246477-B2 Isomerisation of C4-C6 aldoses with zeolites ALDOA, ME1, LCT CDK1 2859/4885CCNB1 1104/4885CA2 81/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.